For TIDCs, previous studies showed that the TIM-3 expression inhibits the activation and maturation of DCs, interfering with the ability of endocytosis of extracellular DNA, thus suppressing the anti-tumor immunity in breast cancer [33, 34]. The gene discussed is HAVCR2; the disease is breast cancer.